Funded through the MTPConnect-Supported Targeted Translational Research Acceleration initiative in 2021, ASHRA aims to revolutionise cardiovascular research with a strong focus on clinical impact and entrepreneurship.

Please find the guidelines and EOI here.

Key Details:

  • Four grants, each valued at $100,000, are available.
  • Projects focusing on drug, device, or digital interventions in CVD/stroke/heart failure are encouraged.
  • Eligible projects must demonstrate clear pathways to translational and/or commercialisation success.

Timeline:

  • Expression of Interest (EOI) opens: 20 June 2024
  • EOI closes: 29 July 2024, 5 pm
  • Notification to applicants: 12 August 2024
  • Project must be able to commence immediately, and funds must be spent by 15 December 2025.

Submission Requirements:

  • Use the provided application template.
  • Submit a 2-page Project Summary (excluding CV and team contact details).
  • Include a 1/2-page CV focusing on translation and commercialisation skills for up to 4 Chief Investigators.

For more information and to submit your EOI, please contact Stella Jun, CVMM Research Development Manager, at stella.jun@unsw.edu.au

Completed EOIs should be emailed to medicine.themes@unsw.edu.au by the deadline.